Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AldOst: Interactions Between Adrenal and Parathyroid Glands
NCT02572960Phase 4Completed
- Sponsor
- Aarhus University
- Start
- Oct 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of valsartan in secondary hyperparathyroidism (SHPT) (4 arms), sponsored by Aarhus University. Primary endpoint: Plasma Aldosterone at 12 weeks. Started Oct 2015; status: completed.
02
Drugs
valsartan
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT02572960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02572960.